Page 54 - Read Online
P. 54

Page 6 of 11             Jacoby et al. Mini-invasive Surg 2022;6:58  https://dx.doi.org/10.20517/2574-1225.2022.58

               Table 1. Preoperative patient characteristics and clinical data
                Variables                                            Number
                Number of patients                                   21
                Age (years)                                          72 (72 ± 8.6) [55-90]
                Sex (M/W)                                            14M/7W
                       2
                BMI (kg/m )                                          25 (27 ± 5.9) [19-40]
                ASA class                                            3 (3 ± 0.4)
                Childs-pugh score                                    5 (6 ± 1.0)
                MELD score                                           9 (11 ± 6.0)
                Tumor size (cm)                                      2 (2 ± 1.2) [0.7-3]
                Jaundice at presentation                             21 (100%)
                Preoperative biliary drainage                        21 (100%)
                    ERCP drainage (n)                                    15 (71%)
                    PTC drainage (n)                                     1 (5%)
                    ERCP and PTC drainage (n)                            5 (24%)
                Preoperative positive biopsy (n)                     17 (81%)
                Neoadjuvant therapy (n)                              3 (14%)
                Jaundiced on day of surgery                          13 (62%)
                    Bilirubin 1-3 mg/dL                                  9 (69%)
                    Bilirubin > 3 mg/dL                                  4 (31%)
               ASA: American Society of Anesthesiologists; BMI: body mass index; ERCP: endoscopic retrograde cholangiopancreatography; MELD: Model for
               End-Stage Liver Disease; PTC: percutaneous transhepatic cholangiography. Data in the table are presented as median (mean ± standard
               deviation) [range], where applicable.

               According to the Bismuth classification, four patients had Type I disease, five Type II, 10 Type III, and two
               Type IV. Sixteen patients (76%) required concomitant hepatectomy; one underwent right hepatectomy,
               seven left hepatectomy, and eight central hepatectomy. Operative time was 458 (433 ± 116.9) minutes with
               an EBL of 150 (175 ± 123.8) mL. There were no intraoperative complications and no conversions to open
               surgery. Final pathological outcomes were as follows: four (5 ± 2.9) lymph nodes were examined per case, 0
               (0 ± 0.4) lymph nodes were positive, R0 was attained in 90% (19/21) of cases and R1 in 10% (2/21) [Table 2].

               Following stratification according to the Bismuth classification, there were no statistically significant
               differences between operative times for different Bismuth types (P = 0.69). The EBL for Bismuth Types
               I/II/III/IV was 275/100/150/113 mL, respectively (P = 0.79). The R1 resection rate was 25% (1/4) for
               Bismuth Type I and 20% (1/5) for Bismuth Type II. In the two cases in which R1 resection was not achieved,
               the margins were reported as negative on frozen section; however, the final pathological examination
               revealed microscopic involvement of the margins. All procedures on patients with Bismuth Types III and IV
               achieved clear margins [Table 3].


               Overall, there were three postoperative complications. Two patients developed intra-abdominal fluid
               collections that required intravenous antibiotics and percutaneous drainage. One of them, a 90-year-old
               patient with emphysema, was discharged on postoperative Day 12 and died within 90 days of respiratory
               failure. Another patient developed a small pneumothorax, probably due to a central line placed
               preoperatively. The pneumothorax resolved spontaneously without the need for tube thoracostomy. Median
               LOS was 5 (6 ± 3.4) days with one readmission at 30 days. There were no in-hospital mortalities. At a
               median follow-up time of 21 months, 15 patients were alive with no evidence of disease and six had died
               [Table 4]. The median overall survival had not been reached at the time of analysis. The one-year survival
               rate was 78% and the three- and five-year survival rates were both 60% [Figure 3].
   49   50   51   52   53   54   55   56   57   58   59